Sr Manager, Global Pricing

Work Schedule

Environmental Conditions

Job Description

POSITION SUMMARY:

We are seeking a highly strategic and results-driven leader to drive the transformation of pricing and contracting capabilities across the $0.6B Microbiology Division (MBD).

This role will act as a key business partner to Commercial and Finance leadership with end-to-end ownership of pricing governance contract strategy and price realization performance. The successful candidate will lead a distributed team shape the divisions pricing roadmap and deliver measurable margin expansion and commercial effectiveness.

This is a high-impact role with significant visibility responsible for embedding best-in-class pricing practices strengthening contract discipline and enabling long-term value creation across global markets.

KEY RESPONSIBILITIES:

Pricing Strategy & Transformation

Define and execute the global pricing strategy and roadmap driving initiatives to enhance price realization margin performance and long-term value capture

Lead the evolution of pricing capabilities including segmentation discount governance and value-based pricing approaches

Identify and close pricing performance gaps delivering tangible and measurable business impact

Contracts & Commercial Governance

Own and enhance the contracting framework and governance model ensuring consistency compliance and risk mitigation

Standardize contracting processes templates and approval flows across regions and channels

Partner with Legal and Commercial teams to ensure robust contract structures aligned with business and regulatory requirements

Business Partnering & Commercial Impact

Act as a trusted advisor to Commercial leadership influencing pricing and contracting decisions to support growth and profitability

Drive discount discipline and pricing accountability through structured reviews training and performance management

Collaborate with cross-functional stakeholders (Commercial Finance Sales Operations Legal) to align pricing strategies with business objectives

Analytics Reporting & Performance Management

Lead pricing performance tracking including price realization margin evolution and discount leakage

Deliver actionable insights through advanced analytics to support strategic decision-making

Oversee pricing-related financial processes including rebate governance and reconciliation

Team Leadership

Build lead and develop a high-performing geographically distributed team

Foster a culture of accountability collaboration and continuous improvement

Attract mentor and retain top talent strengthening both technical and leadership capabilities

MINIMUM QUALIFICATIONS

Bachelors degree in Business Finance Economics or related field

10 years of experience in pricing commercial strategy or financial leadership roles within complex global organizations

Proven track record of leading pricing transformation initiatives and delivering measurable margin improvement

Strong experience in pricing governance discount frameworks and commercial policy design

Advanced analytical capabilities with experience leveraging data analytics and data-driven decision making

Demonstrated ability to influence senior stakeholders in a highly matrixed fast-paced environment

Experience building and leading high-performing distributed teams

PREFERRED EXPERIENCE

Experience in Healthcare Life Sciences or manufacturing environments

Exposure to contracting through distribution channels GPOs and rebate structures

Familiarity with value-based pricing and advanced pricing models

Experience working in global cross-regional organizations

Strong change management and transformation mindset

WHY THIS ROLE

Opportunity to shape and build a critical capability within a growing global division

High visibility with senior leadership and direct impact on business performance

Ability to drive meaningful transformation and long-term value creation

Leadership of a strategic high-impact function with global scope

Thermo Fisher Scientific recently announced that it has entered into an agreement to sell its microbiology business to Astorg a leading pan-European private equity firm with deep expertise in healthcare focused on a select set of subsectors including pharmaceutical services and technology medtech and related services life science tools and diagnostics.

This decision follows a thoughtful evaluation as part of Thermo Fishers ongoing business strategy to actively manage and strengthen our portfolio.

We expect the transaction will be completed in the second half of 2026 subject to customary closing conditions and applicable regulatory approvals. Until the transaction is complete Thermo Fisher will continue to operate the business.

If you join the microbiology business prior to the close of the transaction your employment is expected to transition to Astorg.

For more information please review: Thermo Fishers press release Astorg press release